Juno Therapeutics (Germany)
Juno Therapeutics Inc was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Juno Therapeutics (Germany), Germany, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
88%
Total
Publications
86
Total Open
Publications
76
Total
Citations
8K
Open Access
Percentage
88%
Total
Publications
86
Total Open
Publications
76
Total
Citations
8K
Breakdown
Publisher Open
18%
Both
27%
Other Platform Open
43%
Closed
12%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
8
Hybrid 41%
16
No Guarantees 38%
15
Other Platform Open
Domain 82%
49
Institution 33%
20
Other Internet 10%
6
Preprint 8%
5
Public 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 49 |
Europe PMC | Domain | 38 |
The University of Arizona - UA Campus Repository | Institution | 3 |
California Digital Library - eScholarship | Other Internet | 3 |
bioRxiv | Preprint | 3 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |
University of California - eScholarship University of California | Institution | 2 |
Research Square | Preprint | 2 |
DOI | Other Internet | 2 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |